Crossref indexed

Cancer Immunology Immunotherapy

Published by Springer-Verlag.

ISSN 0340-7004 / 1432-0851
Submit to this journal
01

Aims & scope

Cancer Immunology Immunotherapy publishes peer-reviewed research. Manuscripts pass a technical check and a scope check by the handling editor before going to independent reviewers.

02

Recently published

DOI 10.1007/s00262-026-04571-0
TREM2 blockade reprograms HER2 CAR macrophages toward inflammatory phagocytes in breast cancer models
Jassaud Marius, Ziane-Chaouche Lydia, Raffo-Romero Antonella, Salzet Michel, Duhamel Marie · 2026
DOI 10.1007/s00262-026-04576-9
Vaccination against neoantigens induced in cross-priming cDC1 in vivo
Emily S. Clark, Ana Paula Benaduce, Wasif N. Khan, Olivier Martinez, Eli Gilboa · 2024
DOI 10.1007/s00262-023-03597-y
Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors
M Costa-Garcia, JJ Rojas, MD Ramos, P Barlabé, P Calvo, J Navas, R Alemany, R Moreno · 2024
DOI 10.1007/s00262-023-03611-3
Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis
K. E. Blethen, C. P. Wolford, G. L. Pecar, T. A. Arsiwala, E. Adjeroh, L. P. Dykstra, B. N. Kielkowski, P. R. Lockman · 2024
DOI 10.1007/s00262-023-03599-w
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice
Akashdip Singh, Eline T. A. M. Mommers-Elshof, Saskia V. Vijver, J. H. Marco Jansen, Susanne Gonder, Robert Jan Lebbink, Dominique Bihan, Richard W. Farndale, Louis Boon, Solomon Langermann, Jeanette H. W. Leusen, Dallas Flies, Linde Meyaard, M. Ines Pascoal Ramos · 2024
DOI 10.1007/s00262-023-03600-6
Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases
Celine Man Ying Li, Yoko Tomita, Bimala Dhakal, Teresa Tin, Runhao Li, Josephine A. Wright, Laura Vrbanac, Susan L. Woods, Paul Drew, Timothy Price, Eric Smith, Guy J. Maddern, Kevin Fenix · 2024
DOI 10.1007/s00262-023-03591-4
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study
Kinnosuke Matsumoto, Takayuki Shiroyama, Motohiro Tamiya, Toshiyuki Minami, Yuhei Kinehara, Akihiro Tamiya, Yasuhiko Suga, Tomoki Kuge, Masahide Mori, Hidekazu Suzuki, Satoshi Tobita, Kiyonobu Ueno, Yoshinobu Namba, Satoshi Tetsumoto, Toshie Niki, Osamu Morimura, Akio Osa, Kazumi Nishino, Izumi Nagatomo, Yoshito Takeda, Takashi Kijima, Atsushi Kumanogoh · 2024
DOI 10.1007/s00262-023-03583-4
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
Joanna Baginska, Allison Nau, Ilana Gomez Diaz, Anita Giobbie-Hurder, Jason Weirather, Juliana Vergara, Charlotte Abrecht, Margaret Hallisey, Jenna Dennis, Mariano Severgnini, Julia Huezo, Isabella Marciello, Osama Rahma, Michael Manos, Andrew S. Brohl, Philippe L. Bedard, Daniel J. Renouf, Elad Sharon, Howard Streicher, Patrick A. Ott, Elizabeth I. Buchbinder, F. Stephen Hodi · 2024
DOI 10.1007/s00262-023-03593-2
Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression
Tommaso Montecchi, Giulia Nannini, Domiziana De Tommaso, Chiara Cassioli, Federica Coppola, Maria Novella Ringressi, Fabio Carraro, Antonella Naldini, Antonio Taddei, Giuseppe Marotta, Amedeo Amedei, Cosima T. Baldari, Cristina Ulivieri · 2024
DOI 10.1007/s00262-023-03614-0
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy · 2024
DOI 10.1007/s00262-023-03607-z
Journal metrics
Total DOIs7,735
Current DOIs1,006
Backfile DOIs6,729
Published here0

Publish with us

Five steps, about 15 minutes. You can save and come back at any point.

Submit manuscript